Pasithea Therapeutics Corp. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Pasithea Therapeutics Corp. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Pasithea Therapeutics Corp. Debt-to-equity for the quarter ending September 30, 2024 was 9.78 %, a 36.4% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	9.78	+2.61	+36.4%	Sep 30, 2024
Q2 2024	10.3	+3.58	+53.5%	Jun 30, 2024
Q1 2024	9.4	+3.86	+69.6%	Mar 31, 2024
Q4 2023	8.28	+4	+93.5%	Dec 31, 2023
Q3 2023	7.17	+3.47	+93.9%	Sep 30, 2023
Q2 2023	6.69	+1.3	+24.1%	Jun 30, 2023
Q1 2023	5.54			Mar 31, 2023
Q4 2022	4.28			Dec 31, 2022
Q3 2022	3.7			Sep 30, 2022
Q2 2022	5.39			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.